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Background: Physiological vasculogenesis in embryonic tissues share some important features with pathological
neoangiogenesis in tumors. Linearly Patterned Programmed Cell Necrosis (LPPCN) and Vasculogenic Mimicry (VM)
have been reported in tumors. The term VM refers to the aggressive tumor cells with CD31-negative phenotype
to form Periodic Αcid Schiff (PAS)-positive network, that mimics the pattern of embryonic vasculogenic networks.
LPPCN had been observed in our laboratory, and served as a spatial infrastructure for VM and endothelium-dependent
vessel formation. Studies have been shown that hypoxia-inducible factor-1α (HIF-1α) can induce tumor cells to form
vessel-like tubes and express genes associated with VM. Therefore, an analogous investigation has been carried out to
determine if these patterns existed in mouse embryonic vasculogenesis.
Results: In this essay, the results demonstrated that the number of Linearly Patterned Cell Αpoptosis (LPCA), embryo
Vasculogenic Μimicry (embryo VM), endothelium-dependent vessels, and relative-protein of HIF-1α expression all
showed time-dependent tendencies on E5.5-E9.5 (p < 0.05). The proteins CD133, VEGF, Twist, E-cadherin, and Vimentin
showed local plexus distribution on E6.5-E7.5 (p < 0.05).
Conclusions: LPCA and embryo VM existed in embryonic vasculogenesis. The relative protein of HIF-1α regulated the
mouse embryonic vasculogenesis.
Keywords: Embryo vasculogenic mimicry, Hypoxia, Hypoxia-inducible factor-1α, Linearly patterned cell apoptosisBackground
Adequate nutrient and substrate supply is essential for
normal fetal intrauterine development. Vasculogenesis
and angiogenesis are two consecutive processes during
embryonic development. Vasculogenesis, the formation of
the first blood vessels, is achieved by the differentiation of
pluripotent mesenchymal cells into hemangiogenic stem
cells. The subsequent step, angiogenesis, is characterized
by the development of new vessels from already existing
vessels [1]. The initial formation of blood vessels in
embryonic tissues is similar to that of pathological neo-
angiogenesis in tumors. For example, they proliferate,
migrate and invade through extracellular matrix and they
have the ability to access the host vasculature and recruit* Correspondence: baocunsun@gmail.com
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unless otherwise stated.a blood supply. However, physiologic neovascularization
is tightly regulated, both temporally and spatially, and
tumor angiogenesis is characterized by uncontrolled neo-
vascularization [2,3]. Many of the genes upregulated by
aggressive tumor cells, which are involved in angiogenesis
and vasculogenesis, have been shown to be involved in
development, such as Vascular Endothelial Growth Factor
(VEGF), Erythropoietin-Producing Hepatocellular Carcin-
oma-A2 (EPHA2), and so on. The cDNA microarray results
showed a genetic reversion to a pluripotent embryonic-like
genotype in the highly aggressive tumor cells [4-6].
LPPCN and VM have been reported in our laboratory
that participated in the tumor blood supply in a time-
dependent trend [7]. Studies have been shown that HIF-
1α is switched under hypoxic conditions. HIF-1α induces
angiogenesis by regulating a cohort of molecules, such
as VEGF, Flt-1, and so on. Interestingly, HIF-1α may
promote tumor cell reprogramming into endothelium cell
by regulating Twist and VE-cadherin [8,9]. However, thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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genesis have not yet been identified.
In 1999, the concept of VM was introduced to describe
the unique ability of highly aggressive tumor cells to form
PAS-positive and CD31-negative cells with a capillary-like
structure and matrix-rich patterned network that mimics
the embryonic vasculogenic network [5]. In tubular-type
VM, non-endothelial cell-lined tubes resembling blood
vessels are identified [10]. The term LPPCN refers to
tumor cells darkly stained with H & E staining distrib-
uted in patterns of lines and networks. The distribution
is similar to that seen in VM networks and endothelium-
dependent vessels. LPPCN showed a form of “initiative
death” that tumor cells were formed under hypoxic micro-
environment. Currently, the vacuity formed by LPPCN
was assumed to provide basis for VM and endothelium-
dependent vessels [7]. Consequently, we used Kunming
mice as a model to observe these phenomena involved in
the embryo and analyze the relationship between them.
Results
Embryo VM and LPCA in the embryo
Some embryo cells were darkly stained in the H & E stained
sections on E5.5-E8.5. These darkly stained embryo cells
arranged in 2-3 rows and there were approximately 20
cells in each row. Morphologically, these cells displayed
pyknosis, cytoplasm concentration, and chromatin conden-
sation. These cells were distributed in patterns of lines and
networks. The distribution and morphological changes of
these cells were similar to those in LPPCN in a tumor.
Thus, we coined the term ‘LPCA’ to describe these darkly
stained cells with special distribution patterns (Figure 1,
B1-B3). The results also showed that the nuclei of LPCA
were positive for TUNEL staining (Figure 1, B4-B6). Some
vessel channels surrounded by embryo cells were negative
for CD31 and positive for PAS staining. The channels
were not composed of endothelial cells and red cells
were found in it. Their structure was similar to that of
VM in tumors. Hence, we coined the term ‘embryo
VM’ to describe it (Figure 1, B7-B9). CD31 is a marker
of endothelial cells, and the base membrane of endo-
thelial cells is positive for PAS. Therefore, CD31 and
PAS dual staining was used to distinguish embryo VM
and endothelial-dependent vessels. We also observed
endothelial-dependent vessels that were lined with
both CD31-positive/PAS-positive cells (Figure 1, B10-
B12). In summary, LPCA, embryo VM, and endothelium-
dependent vessels existed in the embryonic development
in the same period (Figure 1 and Table 1).
To determine the pattern of embryo blood supply at
different stages of embryo growth, we measured the
density of each type of vessel (MVD) daily from E5.5.
The density of embryo VM was found to increase from
E5.5 to E7.5, and then decreased from E8.5 to E9.5 inthe inner zone and outer area, respectively. The density
of LPCA peaked in E6.5, whereas that for embryo VM
peaked on E7.5. MVD increased from E5.5 to E9.5. We
observed elongated vessels from the periphery on E7.5,
but most of them failed to mature. Vessels were formed
in the networks in one terminal of the embryo on E9.5.
Therefore, embryo VM was the major pattern of blood
supply for embryonic growth at the early stages, and
endothelium-dependent vessels dominated at the ad-
vanced stages of embryo growth. The change of LPCA,
embryo VM, and endothelium-dependent vessels was
time-dependent (p < 0.05) (Figure 1C and Table 1). LPCA
may eventually form a channel-shaped, vessel-like empty
space left by dead cells, as well as a supply space for
embryo VM and endothelium-dependent vessels.Expression of CD133, HIF-1α, and VEGF at different stages
of embryonic growth
By immunohistochemical staining, the expression of CD
133 was in the cytoplasm and membrane of embryo
cells, HIF-1α in the cytoplasm and nucleolus of embryo
cells, as well as VEGF in the cytoplasm of embryo cells.
The expression intensities of VEGF, HIF-1α and CD133
in the outer area were higher than those in the inner
zone on E5.5-E6.5 (p < 0.05) (Figure 2A). On E7.5, the
expression intensities of VEGF and CD133 showed local
distribution significantly (Figure 2B). The highest VEGF
expression was in the inner zone on E7.5 and in the
outer zone on E6.5. The highest HIF-1α expression was
in the inner zone on E7.5 and in the outer zone on E6.5
while the highest CD133 expression was in the outer
zone on E6.5 and increased in the inner zone (p < 0.05).
The level of HIF-1α expression decreased on E8.5-E9.5.
VEGF and CD133 expression increased in E9.5 (p < 0.05)
(Figure 2C and Table 2).Expression of twist, E-cadherin, and Vimentin at the
different stages of embryonic growth
Immunohistochemical staining revealed the expression
of E-cadherin in the cytoplasm and membrane of
embryo cells, Twist in the cytoplasm and nucleolus of
embryo cells, as well as Vimentin in embryonic interstitial
tissues. The expression intensities of Twist, E-cadherin,
and Vimentin in the outer area were higher than those
in the inner zone on E5.5-E6.5 (p < 0.05) (Figure 3A).
On E7.5, the expression intensities of Twist, E-cadherin,
and Vimentin showed local distributions significantly
(Figure 3B). Twist protein expression around the ves-
sels was observed. The highest expression of Twist
and Vimentin appeared in the inner and outer zones
on E7.5 (p < 0.05). The highest E-cadherin expression
was in the inner zone on E8.5 and in the outer zone
on E6.5. The expression of Twist increased on E9.5,
Figure 1 Evidence of linearly patterned cell apoptosis and embryo vasculogenic mimicry in mouse embryonic vasculogenesis. (A)
Morphological observation of embryonic development by the naked eye (A1-A5) and under microscopy (A6-A10). The boundary between inner
and outer zones is indicated by arrows. (B) Morphological observation of vessel pattern changed during E5.5-E9.5 in LPCA (H & E staining, ×200),
embryo VM (CD31/PAS staining, ×400), and endothelium-dependent vessels (CD31 staining, ×400). Embryo cells (green arrow) displayed pyknosis,
cytoplasm concentration, and chromatin condensation in LPCA areas. These darkly stained cells were distributed in lines and network patterns (B1-B3).
The embryonic cells undergoing apoptosis displayed positive TUNEL staining (black arrows, ×400). They also had a distribution in lines and network
patterns (B4-B6). The channels (yellow arrow) lined with embryo cells containing red blood cells was embryo VM. Embryo cells were negative for CD31
and positive for PAS staining (B7-B9). The endothelium-dependent vessels from E5.5 to E9.5 were shown by the red arrow (B10-B12). (C) The bar
diagram represents the changed in LPCA, embryo VM, and endothelium-dependent vessels with time from E5.5 to E9.5 in the inner (C1) and outer
zones (C2), respectively (p < 0.05).
Table 1 The value of linearly patterned cell apoptosis, embryo vasculogenic mimicry and endothelium-dependent
vessels (x—±SD)
Linearly patterned cell apoptosis Embryo vasculogenic mimicry Endothelium-dependent vessels
Inner zone Outer zone Inner zone Outer zone Inner zone Outer zone
E5.5 5 ± 0.58 25 ± 0.88 3 ± 0.58 14 ± 1.74 4 ± 0.58 20 ± 2.88
E6.5 10 ± 1.16 35 ± 2.89 4 ± 0.53 15 ± 1.15 10 ± 2.89 30 ± 5.19
E7.5 5 ± 1.05 15 ± 1.45 5 ± 0.88 18 ± 2.89 15 ± 1.45 35 ± 2.02
E8.5 4 ± 0.67 6 ± 0.75 1 ± 0.33 8 ± 1.73 20 ± 4.62 40 ± 4.62
E9.5 1 ± 0.55 1 ± 0.33 1 ± 0.47 1 ± 0.33 40 ± 4.74 55 ± 2.79
F-value 14.32 76.95 10.93 13.95 17.75 12.13
p < 0.001 < 0.001 0.001 < 0.001 < 0.001 0.001
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Figure 2 Evidence of the expression of HIF-1α, VEGF, and CD133 proteins in mouse embryonic vasculogenesis. (A) Morphological
observations of HIF-1α, VEGF and CD133 protein expression changed in E5.5-E9.5 with IHC staining (A1-A3, ×400; A4-A12, ×40). HIF-1α positive expression
in embryo cells was identified in the cytoplasm as well as in nucleolus (A1). VEGF positive expression in embryo cells was identified in the cytoplasm (A2),
CD133 positive expression in embryo cells was identified in the cytoplasm and membrane (A3). A marked change between the inner and outer zones
can be observed in the figure (A4-A12). (B) Morphological observations of CD133 and VEGF protein expression showed an irregular liner pattern in
E6.5-E7.5 and the pattern was similar to endothelium-dependent vessels distribution with IHC staining (B1-B2, ×200). (C) The bar diagram represents
the changed in the expression of the three proteins with time from E5.5 to E9.5 in the inner (C1) and outer zones (C2), respectively (p < 0.05).
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Table 2 The expression of HIF-1α, VEGF and CD133 proteins in mouse embryonic vasculogenesis (x—±SD)
HIF-1α VEGF CD133
Inner zone Outer zone Inner zone Outer zone Inner zone Outer zone
E5.5 10.0 ± 1.58 55.6 ± 4.04 15.0 ± 4.12 60.2 ± 3.96 12.0 ± 3.08 63.4 ± 4.22
E6.5 15.2 ± 1.92 74.8 ± 3.56 29.6 ± 3.65 70.0 ± 3.81 19.0 ± 4.18 69.6 ± 3.65
E7.5 17.8 ± 1.92 65.4 ± 3.85 41.0 ± 3.81 59.6 ± 3.21 25.0 ± 3.54 60.0 ± 3.54
E8.5 11.0 ± 3.39 57.6 ± 2.07 30.4 ± 3.64 45.0 ± 4.12 29.0 ± 4.18 39.0 ± 4.18
E9.5 6.60 ± 2.07 40.0 ± 3.81 31.2 ± 2.77 49.0 ± 5.43 40.4 ± 4.16 45.6 ± 3.78
F-value 18.96 66.36 32.88 28.28 54.02 38.54
p < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
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E9.5 (p < 0.05) (Figure 3C and Table 3).
Discussion
Adequate nutrient and substrate supply is essential for
normal fetal intra-uterine development. Embryonic angio-
genesis involved a complex series of events during whichFigure 3 Evidence of the expression of Twist, E-cadherin, and Viment
observation of the changes in the expression of Twist, E-cadherin, and Vimen
A4-A12, ×40). Twist positive expression in embryo cells was identified in the c
embryo cells was identified in the cytoplasm and membrane (A2). Vimentin p
(A3). The marked change between the inner and outer zones can be observe
expression in the adjacent area of vessels (B1, ×400). Morphological observatio
pattern during E6.5-E7.5 with IHC staining (B2-B4, ×200). (C) The bar diagram
from E5.5 to E9.5 in the inner (C1) and outer zones (C2), respectively (p < 0.05endothelial cells differentiate, proliferate, migrate, and
undergo maturation into an organized vascular network
[11]. In mammals, vascular progenitors first appeared
in the yolk sac, where extra-embryonic mesodermal
precursors of both hematopoietic and endothelial lineages
differentiate into solid clumps, which begin to form mor-
phologically identifiable “blood islands” on E6-E6.5 [12].in proteins in mouse embryonic vasculogenesis. (A) Morphological
tin protein expression from E5.5 to E9.5 with IHC staining (A1-A3, ×400;
ytoplasm as well as in nucleolus (A1). E-cadherin positive expression in
ositive expression in embryo cells was identified in the interstitial tissue
d in the figure (A6-A12). (B) Morphological observation of Twist protein
n of Twist, E-cadherin, and Vimentin protein expression showed a patchy
represents the changed in the expression of the three proteins with time
).
Table 3 The expression of twist, E-cadherin and Vimentin proteins in mouse embryonic vasculogenesis (x—±SD)
Twist E-cadherin Vimentin
Inner zone Outer zone Inner zone Outer zone Inner zone Outer zone
E5.5 21.6 ± 2.70 60.0 ± 3.39 14.8 ± 2.39 20.0 ± 2.54 10.2 ± 1.92 59.6 ± 3.04
E6.5 25.0 ± 2.55 74.8 ± 2.39 18.0 ± 2.55 34.6 ± 3.07 15.2 ± 2.86 65.2 ± 2.86
E7.5 30.0 ± 3.05 77.8 ± 1.92 15.0 ± 2.07 25.2 ± 1.92 21.2 ± 2.77 70.2 ± 1.92
E8.5 26.4 ± 2.70 65.0 ± 2.55 20.0 ± 1.92 31.2 ± 3.96 16.4 ± 2.07 50.4 ± 2.07
E9.5 20.0 ± 2.55 69.8 ± 2.39 12.0 ± 2.07 15.4 ± 2.07 13.2 ± 1.64 46.4 ± 2.41
F-value 21.91 39.19 60.31 134.67 15.61 89.05
p < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
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on E7-E7.5 [13]. In the rapid growth stage, the blood
supply arrived the “blood islands” was not satisfied the
oxygen and nutritional needs of embryonic development
on E5.5-E7.5. Embryo proper cells have been suffered
from anoxia on E5.5-E7.5.
Hypoxia is an elemental physiological stimulus that
occurs in response to tissue growth during normal de-
velopment [14]. Hypoxia occurs when oxygen supply is
decreased and/or demand is relatively increased during
normal development. A large number of genes involved
in different steps and individual phenotypic processes
of angiogenesis are known to be regulated by hypoxia.
HIF-1α plays an important role in this process [15] and
LPCA was formed under hypoxia conditions and regulated
by a series of genes. We presumed that the moribund cells
from LPCA may provide transient spatial infrastructure
for embryo VM as well as endothelium-dependent vessel
in developmental processes. At the same time, embryo
cells around the LPCA remold to form embryo VM.
Similar results have been observed in tumor by our
earlier experiment [7,16].
The results showed that embryo VM was the main
pattern of blood supply for the embryo on E5.5-E7.5. As
the embryo expanded, endothelial cells differentiated
and proliferated. Consequently, endothelium-dependent
vessels replaced embryo VM as the major pattern of
blood supply on E8.5-E9.5. Presumably, this observation
was based on the fact that LPCA, embryo VM and
endothelium-dependent vessels existed in embryo by
time-dependent manner.
The immunohistochemical data also revealed that
regions of LPCA were positive for HIF-1α and negative
for VEGF and CD133 on E5.5-E7.5. HIF-1α-VEGF axis
regulating angiogenesis program plays a critical role in
ischemic tissue and tumor [17,18]. HIF-1a is a tran-
scription factor selectively stabilized and activated under
hypoxic conditions, and coordinates the adaptive response
of tissues to hypoxia [19]. In our study, LPCA cells were
intensively positive for HIF-1α in the development of
embryo. The highest of LPCA was consistent with thehighest expression of HIF-1α on E6.5. Our study sug-
gested hypoxia relieved when embryo VM was formed
after E7.5. At the same time, the embryonic cells around
the LPCA were positive for VEGF and CD133. VEGF
signaling is the best-known pathway that regulates the
formation and morphogenesis of blood and lymphatic
vessels during development. During development, activa-
tion of the VEGF signaling pathways is the earliest known
landmark that defines the endothelial lineage commitment
within the nascent mesoderm [20]. CD133 transmem-
brane glycoprotein was expressed in hematopoietic stem
cells and Endothelial Progenitor Cell (EPC). The surface
antigen CD133 has been accepted as an alternative EPC
marker because it is not expressed on mature endothelial
cells. CD133 was rapidly downregulated as progenitors
and stem cells differentiate into more mature post-mitotic
cells [21]. Interestingly, the staining intensities of CD133
and VEGF were locally strengthened in the inner fields
on E6.5-E7.5.Their expression in a spatial distribution
suggested patterned networks of channel formation. There-
fore, our experiments indicated that embryo cells, upon
experiencing a hypoxic environment, increased the
expression of HIF-1α at the early stages of embryonic
development. As the embryo developed, HIF-1α activated
VEGF gene expression. Subsequently, VEGF induced EPC
(CD133+) embryo cell differentiation as well as the prolif-
eration and tube formation of embryo VM networks on
E6.5-E7.5. The expression of VEGF and CD133 were
upgraded on E8.5-E9.5. They may promote placenta
formation during this time.
Concurrently, HIF-1α may upregulate Twist, which
induces a series of biological events [22]. In inner fields,
the staining intensity of Twist displays a local plexus
on E6.5-E7.5. Twist reactivity in a spatial distribution
suggested patterned networks formation, which is consist-
ent with the peak formation of embryo VM on E7.5. The
expression of E-cadherin was upregulated and that of
Vimentin was downregulated. We also observed that the
expression of Twist around the vessels was strengthened.
Therefore, we supposed that the Twist relative-protein
participated in embryo VM formation, and had a potential
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sion of Twist enhanced the modality-transmitting ability
of embryo mesenchymal cells to endothelium cells. This
phenomenon has also been observed in tumor angio-
genesis. Twist may promote tumor cell reversion to an
embryonic, more plastic phenotype and take part in
VM formation of tumors [8,18].
In summary, HIF-1α plays a deterministic role in the
developmental processes as well as tumors. On one hand,
HIF-1α promoted VEGF expression, which induces endo-
thelial progenitor cells to differentiate and proliferate. On
the other hand, HIF-1α activated the Twist gene, which
promotes the transition of mesoderm stem cells in the
embryo. In conclusion, HIF-1α promoted the vasculogen-
esis of the embryo via different ways. The results were
consistent with the hypothesis that the genetic ablation
of HIF-1α in mice resulted in embryonic lethality at mid-
gestation and caused vascularization defects [23].
Conclusions
Based on our observation and investigation, we described
these interesting phenomena and established a model
of vessel generation during embryonic development. The
LPCA and embryo VM had been formed under local
hypoxia environment during the early stage of embryonic
growth. LPCA may serve as the spatial foundation for
further blood vessel development. Often, understanding
of active biological processes during development may
suggest molecular mechanisms underlying the neoplastic
transformation [24,25]. This study made provide a solid
basis for understanding the biological feature of a tumor.
Meanwhile, the study made also provide promising thera-
peutic target for the treatment of tumor.
Methods
Animal and pregnant animal model
Kunming mice (aged 6-8 weeks, 10 males and 25 females)
were purchased from the Animal Base of Union Drug
Institute (Beijing, China). The average weights were
35-40 g for males and 25-35 g for females. The ratio
between females and males in the same cage was 3:1.
The noon of the day on which the vaginal plug is
found was observed as E0.5 after gestation [26]. The
pregnant mice were randomly divided into five groups:
E5.5 (5.5 days after pregnancy), E6.5 (6.5 days after
pregnancy), E7.5 (7.5 days after pregnancy), E8.5 (8.5 days
after pregnancy), and E9.5 (9.5 days after pregnancy).
The pregnant mice after completing observation were
sacrificed according to the date of pregnancy. All mice
were fed in a temperature-controlled room for one week
before they copulated. All animals were maintained
according to the “Guidelines for the Care and Use of
Experimental Animals” established by the Tianjin Medical
University, China.Immunohistochemistry staining and histochemistry staining
The uterus of pregnant mice were removed, fixed with
formalin, embedded in paraffin, cut into 4 μm sections, and
mounted onto poly-L-lysine-coated slides. The sections
were routinely deparaffinized, and endogenous peroxidase
activity was blocked with 3% hydrogen peroxide in 100%
methanol for 30 min at room temperature. The sections
were rehydrated and washed with Phosphate-Buffered
Saline (PBS), and pretreated with citrate buffer (0.01 M
citric acid, pH 6.0) for 20 min at 100°C in a microwave
oven. After the nonspecific binding sites were blocked
using normal goat serum for 30 min at room temperature,
the sections were incubated overnight at 4°C with rabbit
polyclonal anti-CD31 (1:100 dilution, Abcam, UK), rabbit
polyclonal anti-VEGF (1:400 dilution, Thermo Scientific,
UK), rabbit polyclonal anti-CD133 (1:100 dilution, Santa
Cruz Biotechnology, CA), mouse monoclonal anti-HIF-1α
(1:50 dilution, Thermo Scientific, UK), rabbit polyclonal
anti-Twist (1:100 dilution, Santa Cruz Biotechnology, CA),
rabbit polyclonal anti-E-cadherin (1:100 dilution, Santa
Cruz Biotechnology, CA), and rabbit polyclonal anti-
Vimentin (1:100 dilution, Epitomics, USA). The sections
were then rinsed with PBS, and biotin-labeled secondary
antibodies and peroxidase-labeled avidins were applied
to the sections at room temperature for 1 hr. The sections
were stained with 3,3΄-diaminobenzidine (DAB) chromo-
gen for 5-10 min at room temperature, and washed with
distilled water. After IHC staining for CD31, the sections
were washed with distilled water for 5 min and incubated
with PAS for 15 min. Finally, all sections were counter-
stained with hematoxylin, dehydrated, and mounted.
Normal human stomach mucous membrane was used
as a positive control for PAS staining. PBS was used in
place of the primary antibodies as a negative control. The
tissue section was used as a positive control according to
the antibody instructions. Immunohistochemistry staining
results were quantified based on the percentage of positive
expression cell area in specific areas.
All sections have been observed by two pathologists
and counting performed by them. They did the counting
blinded as to the day of gestation.
Quantification of Microvessel Density (MVD)
According to the protocol introduced by Weidner [7],
capillary vessels and microvessels in the embryo stained
with CD31 were counted. A single positively stained endo-
thelial cell can be counted as one MVD.
Quantification of embryo VM
The characteristics of embryonic VM referred to define of
tumor VM [6]. The wall of embryo VM was lined with
embryonic cells. Red cells can be found in the embryo
VM tube. The counting of embryonic VM referred to
counting of tumor VM [27]. Embryo VM channels in
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using × 400 magnification. Five fields were randomly
chosen, and the average blood supply pattern was defined
as the number of microvessels or channels in one section.
Quantification of LPCA
The constitution of some embryo cells that were darkly
stained in the H & E stained sections were distributed
in patterns of lines and networks, and termed as LPCA.
The count of LPCA was the percentage of the LPCA
cell area in specific areas. LPCA in the H&E staining
sections were counted under × 200 magnification. The
results presented are mean of the five fields.
TUNEL staining
For in situ visualization of apoptotic cell distribution,
we applied the terminal dexynucleotidyl transferase (TdT)-
mediated dUTP nick end labeling (TUNEL) staining using
an apoptotic cell detection kit (TUN11684817, Roche, USA)
following the manufacturer’s directions.
Statistical analysis
All data in the study were evaluated with SPSS version
13.0 (SPSS Inc., Chicago, IL, USA), and p < 0.05 was
considered statistically significant. Statistical analysis was
performed using one-way ANOVA.
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